谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Abstract OT2-03-01: Heredera Breast Cancer: Phase III Study of First-Line, Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection ± Giredestrant (GDC-9545) for Estrogen Receptor+, HER2+ Advanced Breast Cancer

Sherko Küemmel,Catherine Harper-Wynne,Yeon H. Park,Fábio Franke,Michelino De Laurentiis,Eva Schumacher-Wulf,Daniel Eiger,Sarah Heeson,Mahesh Shivhare,Eleonora Restuccia,Joyce O’Shaughnessy

Cancer research（2023）

引用 0|浏览47
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要